Interferon resistance of hepatitis C virus genotype 1b: Relationship to nonstructural 5A gene quasispecies mutations

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 2795-2805

  Pawlotsky, Jean Michel ^a   Germanidis, Georgios ^a   Neumann, Avidan U ^b   Pellerin, Muriel ^a   Frainais, Pierre Olivier ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; GENE ASSIGNMENT; GENE MUTATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0031923838     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.2795-2805.1998     Document Type: Article

References (81)

1. Alter, H. J. 1995. To C or not to C: these are the questions. Blood 85: 1681-1695.
2. Baron, S., S. K. Tyring, W. R. Fleischmann, D. H. Coppenhaver, D. W. Niesel G. R. Klimpel, G. J. Stanton, and T. K. Hughes. 1991. The interferons Mechanisms of action and clinical applications. JAMA 266:1375-1383.
3. Chayama, K., A. Tsuboto, M. Kobayashi, K. Okamoto, M. Hashimoto, Y. Miyano, H. Koike, M. Kobayashi, I. Koida, Y. Arase, S. Saitoh, Y. Suzuki, N. Murashima, K. Ikeda, and H. Kumada. 1997. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
4. Chemello, L., L. Cavalletto, C. Casarin, P. Bonetti, E. Bernardinello, P. Pontisso, C. Donada, F. Belussi, S. Martinelli, A. Alberti, and the TriVeneto Viral Hepatitis Group. 1996. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C. Ann. Intern. Med. 124:1058-1060.
5. Chumakov, K. M. 1996. PCR engineering of viral quasispecies: a new method to preserve and manipulate genetic diversity of RNA virus populations. J. Virol. 70:7331-7334.
6. Clarke, D. K., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. Holland. 1994. The red queen reigns in the kingdom of RNA viruses. Proc. Natl. Acad. Sci. USA 91:4821-4824.
7. Coffin, J. M. 1995. HIV population dynamics in vivo: implications tor genetic variation, pathogenesis, and therapy. Science 267:483-489.
8. Conjeevaram, H. S., J. E. Everhart, and J. H. Hoofnagle. 1995. Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1326-1329.
9. Davis, G. L. 1994. Prediction of response to interferon treatment of chronic hepatitis C. J. Hepatol. 21:1-3.
10. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goodsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
11. Dockter, J., C. F. Evans, A. Tishon, and M. B. A. Oldstone. 1996. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J. Virol. 70:1799-1803.
12. Domingo, E. 1996. Biological significance of viral quasispecies. Viral Hepatitis Rev. 2:247-261.
13. Duarte, E. A., I. S. Novella, S. C. Weaver, E. Domingo, S. Wain-Hobson, D. K. Clarke, A. Moya, S. F. Elena, J. C. de la Torre, and J. J. Holland. 1994. RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis. 3:201-214.
14. Eigen, M., and C. Biebrieher. 1988. Role of genome variation in virus evolution, p. 211-245. In E. Domingo, J. Holland, and P. Ahlquist (ed), RNA genetics, volume 3. Variability of RNA genomes. CRC Press, Inc., Bocan Raton, Fla.
15. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96:224-230.
16. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med 334:77-81.
17. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
18. Feller, J. A., K. Grace, B. E. Clarke, and J. Y. N. Lau. 1996. Variations in the translational efficiency of naturally occurring hepatitis C virus (HCV) variants. Implication for the design of antiviral therapy. Hepatology 24:263A.
19. Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.
20. Felsenstein, J. 1995. PHYLIP (phylogeny inference package): version 3.57. Distributed by the author. Department of Genetics, University of Washington, Seattle.
21. Gale, M. J., M. J. Korth, N. M. Tang, S. L. Tan, D. A. Hopkins, T. E. Dever, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-2-7.
22. Gonzalez-Peralta, R. P., K. Qian, J. Y. She, G. L. Davis, T. Ohno, M. Mizokami, and J. Y. N. Lau. 1996. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J. Med. Virol. 49:242-247.
23. Gretch, D. R. Personal communication.
24. Gretch, D. R., and S. J. Polyak. 1997. The quasispecies nature of hepatitis C virus: research methods and biological implications, p. 57-72. In Groupe Français d'Etudes Moléculaires des Hépatites (GEMHEP) (ed.), Hepatitis C virus: genetic heterogeneity and viral load. John Libbey Eurotext, Paris, France.
25. Gretch, D. R., S. J. Polyak, J. J. Wilson, R. L. Carithers, J. D. Perkins, and L. Corey. 1996. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J. Virol. 70:7622-7631.
26. Hagiwara, H., N. Hayashi, E. Mita, T. Takehara, A. Kasahara, H. Fusamoto, and T. Kamada. 1993. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 104:877-883.
27. Halimi G., P. Halfon, V. Gerolami, F. Castets, H. Khiri, M. Bourliere, A. P. Gauthier, and G. Cartouzou. 1996. Mutations in NS5A region and interferon response in hepatitis C-1b-infected patients. Hepatology 24:162A.
28. Hijikata, M., H. Mizushima, Y. Tanji, Y. Komoda, Y. Hirowatan, T. Akagi, N. Kato, K. Kimura, and K. Shimotohno. 1993. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. USA 90:10773-10777.
29. Hirowatari, Y., M. Hijikata, and K. Shimotohno. 1995. A novel method for analysis of viral proteinase activity encoded by hepatitis C virus in cultured cells. Anal. Biochem. 225:113-120.
30. Holland, J. J., J. C. De La Torre, and D. A. Steinhauer. 1992. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1-20.
31. Jouët, P., F. Roudot-Thoraval, D. Dhumeaux, J. M. Métreau, and le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C. 1994. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 106:686-690.
32. Jukes, T. H., and T. R. Cantor. 1969. Evolution of protein molecules, p. 21-132. In H. N. Munro (ed.), Mammalian protein metabolism. Academic Press, Inc., New York, N.Y.
33. Kapoor, M., L. Zhang, M. Ramachandra, J. Kusukawa, K. E. Ebner and R. Padmanabhan. 1995. Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol. Chem. 270:19100-19106.
34. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
35. Katze, M. G. Personal communication.
36. Khorsi, H., S. Castelain, A. Wyseur, J. Izopet, V. Canva, A. Rombout, D. Capron, J. P. Capron, F. Lunel, L. Stuyver, and G. Duverlie. 1997. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients. J. Hepatol. 27:72-77.
37. Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996 Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-365.
38. Koup, R. A. 1994. Virus escape from CTL recognition. J. Exp Med. 180: 779-782.
39. Koziel, M. J., D. Dudley, N. Afdhal, Q. L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T-lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
40. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q. L. Choo, M. Houghton, and B. D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokines release. J. Clin. Invest. 96:2311-2321.
41. Kumar, S., K. Tamara, and M. Nei. 1993. MEGA: molecular evolutionary genetic analysis for microcomputers. Comput. Appl. Biosci. 10:189-191.
42. Kurosaki, M., N. Enomoto, T. Murakami, I. Sakuma, Y. Asahma, C. Yamamoto, T. Ikeda, S. Tozuka, N. Izumi, F. Marumo, and C. Sato. 1997. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepatology 25:750-753.
43. Lam, N. P., A. U. Neumann, D. R. Gretch, T. E. Wiley, A. S. Perelson, and T. J. Layden. 1997. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology 26:226-231.
44. Magrin, S., A. Craxi, C. Fabiano, R. G. Simonetti, G. Fiorentino, L. Marino, O. Diquattro, V. di Marco, O. Loiacono, R. Volpes, P. Almasio, M. S. Urdea, P. Neuwald, R. Sanchez-Pescador, J. Detmer, J. C. Wilber, and L. Pagliaro. 1994. Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment. Hepatology 19:273-279.
45. Mahaney, K., V. Tedeschi, G. Maertens, A. M. Di Bisceglie, J. Vergalla, J. H. Hoofnagle, and R. Sallie. 1994. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411.
46. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
47. Martell, M., J. I. Esteban, J. Quer, V. Vargas, R. Esteban, J. Guardia, and J. Gomez. 1994. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J. Virol. 68:3425-3436.
48. Martinot-Peignoox, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Le Breton, V. Milotova, J. P. Benhamou, and S. Erlinger. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
49. Murakami, T., N. Enomoto, Y. Asahina, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in NS5A region and response to interferon in HCV genotype 2 infection. Hepatology 24:158A.
50. Niiyama, G., T. Kimura, K. Mitani, H. Tsugeno, N. Sengoku, S. Kinoyama, T. Ito, M. Kinoshita, and G. Yamada. 1996. Mutations in the nonstructural protein 5A gene in chronic hepatitis C virus 1b infection patients with interferon treatment. Hepatology 24:164A.
51. Nousbaum, J. B., S. Pol, B. Nalpas, P. Landais, P. Berthelot, C. Bréchot, and the Collaborative Study Group. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Ann. Intern. Med. 122:161-168.
52. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611.
53. O'Connell, J. F. 1997. Mechanisms of action of interferon: potential role in hepatitis C. Viral Hepatitis Rev. 3:121-128.
54. Orita M., Y. Suzuki, T. Sekiya, and K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
55. Orito, E., M. Mizokami, K. Suzuki, K. I. Ohba, T. Ohno, M. Mori, K. Hayashi, K. Kato, S. Iino, and J. Y. N. Lau. 1995. Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J. Med. Virol. 46: 109-115.
56. Overton, H., D. McMillan, F. Gillespie, and J. Mills. 1995. Recombinant baculovirus-expressed NS3 proteinase of hepatitis C virus shows activity in cell-based and in vitro assays. J. Gen. Virol. 76:3009-3019.
57. Pawlotsky, J. M. 1997. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 26:1-4.
58. Pawlotsky, J. M., A. Fleury, V. Choukroun, L. Deforges, F. Roudot-Thoraval, P. Aumont, J. Duval, and D. Dhumeaux. 1994. Significance of highly positive C22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J. Clin. Microbiol. 32:1357-1359.
59. Pawlotsky, J. M., A. G. Hovanessian, F. Roudot-Thoraval, P. Lebon, N. Robert, M Bouvier, G. Babany, J. Duval, and D. Dhumeaux. 1995 Activity of the interferon-induced 2′-5′-oligoadenylate synthetase in patients with chronic hepatitis C. J. Interferon Cytokines Res. 15:857-862.
60. Pawlotsky, J. M., F. Roudot-Thoraval, A. Bastie, F. Darthuy, J. Rémiré, J. M. Métreau, E. S. Zafrani, J. Duval, and D. Dhumeaux. 1996. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J. Infect. Dis. 174: 1-7.
61. Pawlotsky, J. M., et al. Unpublished data.
62. Plyusnin, A., Y. Cheng, H. Lehvaslaiho, and A. Vaheri. 1996. Quasispecies in wild-type Tula hantavirus populations. J. Virol. 70:9060-9063.
63. Poynard, T., V. Leroy, M. Cohard, T. Thevenot, P. Mathurin, P. Opolon, and J. P. Zarski. 1996. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24: 778-789.
64. Reed, K. E., J. Xu, and C. M. Rice. 1997. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J. Virol. 71:7187-7197.
65. Rosa, D., S. Campagnoli, C. Moretto, E. Guenzi, L. Cousens, M. Chin, L. Dong, A. J. Weiner, J. Y. N. Lau, Q. L. Choo, D. Chien, P. Pileri, M. Houghton, and S. Abrignani. 1996. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorometnc assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93:1759-1763.
66. Roudot-Thoraval, F., A. Bastie, J. M. Pawlotsky, D. Dhumeaux, and the Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. 1997. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6664 patients. Hepatology 26:485-490.
67. Saitou, N., and N. Mei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-423.
68. Sekiya, T. 1993. Detection of mutant sequences by single-strand conformation polymorphism analysis. Mutat. Res. 288:79-83.
69. Serfaty, L., P. Giral, A. Loria, T. Andréani, C. Legendre, and R. Poupon. 1994. Factors predictive of the response to interferon in patients with chronic hepatitis C. J. Hepatol. 21:12-17.
70. Squadrito, G., F. Leone, M. Sartori, B. Nalpas, P. Berthelot, G. Raimondo, S. Pol, and C. Bréchot. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567-572.
71. Tanji, Y., T. kaneko, S. Satoh, and K. Shimotohno. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:3980-3986.
72. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
73. Tilg, H. 1997. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112: 1017-1021.
74. Wain-Hobson, S. 1992. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr. Top. Microbiol. Immunol. 176:181-193.
75. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755-2759.
76. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchison, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
77. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptative evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 272:537-542.
78. Wong, D., M. J. Koziel, and B. D. Walker. Personal communication.
79. Yamashita, T., Y. Shirota, S. Kaneko, K. Kobayashi, and S. Murakami. 1997. RNA-dependent RNA polymerase activity of purified bacterial recombinant hepatitis C virus (HCV) NS5B and its binding activity to HCV NS5A, p. 35. In Abstracts of the 4th International Meeting on Hepatitis C Virus and Related Viruses.
80. Zeuzem, S., J. H. Lee, and W. K. Roth. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25:740-744.
81. Zeuzem, S., J. M. Schmidt, J. H. Lee, B. Rüster, and W. K. Roth. 1996. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23:366-371.